These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38512225)

  • 1. Predicting Liver-Related Outcomes in Steatotic Liver Disease.
    Younossi ZM
    JAMA; 2024 Apr; 331(15):1274-1275. PubMed ID: 38512225
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
    Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
    Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.
    Vilar-Gomez E; Vuppalanchi R; Desai AP; Gawrieh S; Ghabril M; Saxena R; Cummings OW; Chalasani N
    Aliment Pharmacol Ther; 2019 Aug; 50(3):317-328. PubMed ID: 31157422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
    Marengo A; Jouness RI; Bugianesi E
    Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
    Önnerhag K; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.
    Kogiso T; Sagawa T; Kodama K; Taniai M; Hashimoto E; Tokushige K
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1579-1589. PubMed ID: 31975453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.
    Lindenmeyer CC; McCullough AJ
    Clin Liver Dis; 2018 Feb; 22(1):11-21. PubMed ID: 29128051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment of liver fibrosis and prognosis.
    Hagan M; Asrani SK; Talwalkar J
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1251-60. PubMed ID: 26377444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some important points for the selection and exclusion of patients with non-alcoholic fatty liver disease.
    Sertoglu E; Kayadibi H; Uyanik M
    Scand J Gastroenterol; 2015 Feb; 50(2):253-4. PubMed ID: 25437347
    [No Abstract]   [Full Text] [Related]  

  • 13. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
    Younossi Z; Henry L
    Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroscan for the Rest of Us-How to Incorporate Fibroscan Into Management of Patients With Liver Disease.
    Sozio MS
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1714-1717. PubMed ID: 30771497
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to: "Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease".
    Jamialahmadi O; Bianco C; Pelusi S; Romeo S; Valenti L
    J Hepatol; 2021 Jun; 74(6):1494-1496. PubMed ID: 33676949
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Van Natta ML; Clark J; Neuschwander-Tetri BA; Diehl A; Dasarathy S; Loomba R; Chalasani N; Kowdley K; Hameed B; Wilson LA; Yates KP; Belt P; Lazo M; Kleiner DE; Behling C; Tonascia J;
    N Engl J Med; 2021 Oct; 385(17):1559-1569. PubMed ID: 34670043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Mellitus and/or Nonalcoholic Steatohepatitis-related Hepatocellular Carcinoma Showed Favorable Surgical Outcomes After Hepatectomy.
    Liang J; Ariizumi SI; Nakano M; Yamamoto M
    Anticancer Res; 2019 Oct; 39(10):5639-5643. PubMed ID: 31570461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
    Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
    Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
    Önnerhag K; Hartman H; Nilsson PM; Lindgren S
    Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of the Bard Scoring System in Bariatric Surgery Patients with Nonalcoholic Fatty Liver Disease.
    Nassif AT; Nagano TA; Okayama S; Nassif LS; Branco Filho A; Sampaio Neto J
    Obes Surg; 2017 Feb; 27(2):394-398. PubMed ID: 27392972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.